Stephane Bancel Moderna, Inc. (MRNA) insider trading activity

Stephane Bancel is Chief Executive Officer of Moderna, Inc.. Currently has a direct ownership of 5.49 Million shares of MRNA, which is worth approximately $298 Million. The most recent transaction as insider was on Apr 14, 2021, when has been sold 9,000 shares (Common Stock) at a price of $153.75 per share, resulting in proceeds of $1,383,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.49M

0% 3M change

1.05% 12M change

Total Value Held $298 Million

Stephane Bancel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 14 2021	SELL Open market or private sale	$1,383,750 $153.75 p/Share	9,000 Reduced 0.14%	6,358,868 Common Stock
Apr 07 2021	SELL Bona fide gift	-	2,000 Reduced 0.03%	6,367,868 Common Stock
Apr 07 2021	SELL Open market or private sale	$1,184,670 $131.63 p/Share	9,000 Reduced 0.14%	6,369,868 Common Stock
Mar 31 2021	SELL Bona fide gift	-	2,000 Reduced 0.03%	6,378,868 Common Stock
Mar 31 2021	SELL Open market or private sale	$1,089,900 $121.1 p/Share	9,000 Reduced 0.14%	6,380,868 Common Stock
Mar 24 2021	SELL Open market or private sale	$1,233,630 $137.07 p/Share	9,000 Reduced 0.14%	6,391,868 Common Stock
Mar 24 2021	SELL Bona fide gift	-	2,000 Reduced 0.03%	6,389,868 Common Stock
Mar 17 2021	SELL Bona fide gift	-	2,000 Reduced 0.03%	6,400,868 Common Stock
Mar 17 2021	SELL Open market or private sale	$1,348,020 $149.78 p/Share	9,000 Reduced 0.14%	6,402,868 Common Stock
Mar 10 2021	SELL Bona fide gift	-	2,000 Reduced 0.03%	6,411,868 Common Stock
Mar 10 2021	SELL Open market or private sale	$1,199,160 $133.24 p/Share	9,000 Reduced 0.14%	6,413,868 Common Stock
Mar 03 2021	SELL Bona fide gift	-	2,000 Reduced 0.03%	6,422,868 Common Stock
Mar 03 2021	SELL Open market or private sale	$1,310,400 $145.6 p/Share	9,000 Reduced 0.14%	6,424,868 Common Stock
Feb 24 2021	SELL Bona fide gift	-	1,000 Reduced 0.02%	6,433,868 Common Stock
Feb 24 2021	SELL Open market or private sale	$1,353,690 $150.41 p/Share	9,000 Reduced 0.14%	6,434,868 Common Stock
Feb 17 2021	SELL Bona fide gift	-	1,000 Reduced 0.02%	6,443,868 Common Stock
Feb 17 2021	SELL Open market or private sale	$1,568,520 $174.28 p/Share	9,000 Reduced 0.14%	6,444,868 Common Stock
Feb 10 2021	SELL Bona fide gift	-	1,000 Reduced 0.02%	6,453,868 Common Stock
Feb 10 2021	SELL Open market or private sale	$1,644,660 $182.74 p/Share	9,000 Reduced 0.14%	6,454,868 Common Stock
Feb 03 2021	SELL Bona fide gift	-	1,000 Reduced 0.02%	6,463,868 Common Stock
Feb 03 2021	SELL Open market or private sale	$1,408,590 $156.51 p/Share	9,000 Reduced 0.14%	6,464,868 Common Stock
Jan 27 2021	SELL Bona fide gift	-	1,000 Reduced 0.02%	6,473,868 Common Stock
Jan 27 2021	SELL Open market or private sale	$1,361,430 $151.27 p/Share	9,000 Reduced 0.14%	6,474,868 Common Stock
Jan 20 2021	SELL Bona fide gift	-	1,000 Reduced 0.02%	6,483,868 Common Stock
Jan 20 2021	SELL Open market or private sale	$1,120,590 $124.51 p/Share	9,000 Reduced 0.14%	6,484,868 Common Stock

Stephane Bancel

Chief Executive Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account